Inventor
Xavier DUPORTET
Inventor
FR
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes25%
Y02ATechnologies for adaptation to climate change18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C12YEnzymes5%
A61QSpecific use of cosmetics or similar toiletry preparations3%
C07KPeptides2%
PatentTitleYear
12,214,022Sequence-specific antimicrobials by blocking DNA repair202512,214,070Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins202512,098,372Microbiome modulation of a host by delivery of DNA payloads with minimized spread202411,970,716Transcriptional control in prokaryotic cells using DNA-binding repressors202411,952,594Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof202411,946,056Optimized vector for delivery in microbial populations202411,905,516Optimized vector for delivery in microbial populations202411,839,645Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins202311,746,352Microbiome modulation of a host by delivery of DNA payloads with minimized spread202311,690,880Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202311,633,348Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins202311,617,773Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy202311,584,918Transcriptional control in prokaryotic cells using DNA-binding repressors202311,584,781Chimeric receptor binding proteins resistant to proteolytic degradation202311,541,106Method for killing bacteria with an engineered postbiotic202311,534,467Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202211,376,286Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders202211,357,831Sequence-specific antimicrobials by blocking DNA repair202211,224,621Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ELIGO BIOSCIENCE (19)· patent assignee history
2022–2025Patents assigned to PASTEUR INSTITUT (4)· patent assignee history
2022–2025Based in FR· patent location history
2023Patents assigned to ST GALLEN KANTONSSPITAL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ELIGO BIOSCIENCE | 19 | 2022–2025 |
| PASTEUR INSTITUT | 4 | 2022–2025 |
| ST GALLEN KANTONSSPITAL | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 19 | 2022–2025 |